This post highlights important recommendations on DURC to frame what outcomes we hope to see from the NSABB Review.
The Nolan Center on Strategic Weapons at CSR is pleased to announce that it has accepted six remarkable individuals into the 2022-2023 class of the Fellowship for Ending Bioweapons.
By Dr. Dan Regan The Council on Strategic Risks (CSR) hosted a webinar on June 8 titled RADx® Initiative & COVID-19 Solutions: Bioengineering at Unprecedented Speed and Scale. As COVID-19 continues to spread and new variants of concern emerge, testing remains an important public safety tool. In the United States, a critical component of testing…
By Kelly Bridges During the 2014-16 Ebola outbreak in West Africa, healthcare workers were contracting Ebola at an alarming rate. The World Health Organization (WHO) found that those fighting Ebola at the frontlines–in clinics and hospitals–were up to 32 times more likely to contract the disease than the rest of the population. Among the principal…
By Lillian Parr As the COVID-19 pandemic has highlighted, rapid detection and swift information sharing are key to stemming the spread of emergent infectious diseases and their variants. To gain insight into a novel pathogen or variant, it must be quickly sequenced and analyzed to determine what threat it poses and what interventions are most…
By: Dr. Ryan Duncombe Last week, a puzzling new monkeypox outbreak appeared in the United States after new cases popped up in the United Kingdom, Portugal, Spain, and Canada. As of May 20, there are now a total of over 70 confirmed cases in multiple countries. Public health officials are working hard to understand how…
Today the Council on Strategic Risks (CSR) is releasing an update to its report entitled Understanding the Threat of Biological Weapons in a World with COVID-19—with a significantly expanded Part III and an accompanying video call-to-action. The updated report features a new final chapter with policy recommendations that would help accelerate the United States toward…
By Lillian Parr From April 12–14, Built with Biology hosted The Global Synthetic Biology Conference, an annual event that features expert speakers and provides networking opportunities for members of the synthetic biology community. The conference highlighted some exciting new biotechnologies, from novel DNA synthesis techniques to AI-enabled drug discovery, and demonstrated the rapid pace of…
The Council on Strategic Risks (CSR) is expanding our nuclear team in the Janne E. Nolan Center on Strategic Weapons, an institute of CSR. This year, CSR plans to hire 3-5 full time staff members to help advance and expand our vision for reducing the risks of nuclear war and driving momentum toward future arms…
By Ryan Duncombe and Lillian Parr The U.S. State Department has released its 2022 report “Adherence to and Compliance with Arms Control, Nonproliferation, and Disarmament Agreements and Commitments.” The report is an important annual resource—and one of the few public, unclassified U.S. government assessments of biological weapons threats. First, this year’s report indicates widespread compliance…